Our comparative evaluation focused on whole-blood TUG1 expression levels across age- and sex-matched individuals, including Friedreich's ataxia patients (n = 72), heterozygous carriers (n = 68) and healthy controls (n = 43). The gene discussed is TUG1; the disease is Friedreich ataxia.